Accelerated approval of Perjeta (pertuzumab) was granted by the FDA as part of a complete treatment regimen for patients with early stage breast cancer before surgery.
Breast density laws ensure that women receive critical breast-health information, supporters say, but many of the laws broadly classify breast density and fail to account for varying levels of risk.
The use of 40 Gy in 15 fractions over 3 weeks is as effective and causes less damage to nearby tissue than a higher total dose of radiotherapy for breast cancer.
Researchers suggest that recommendations for the universal screening of breast cancer with mammography be reassessed.
Women with a history of cancer are nearly twice as likely to experience severe menopausal symptoms, according to the results of a new study.
Metabolic syndrome is more likely to develop in postmenopausal survivors of breast cancer than in postmenopausal women who never had the disease.
The effects of exercise during and after cancer treatment are different, according to the findings of a new systematic review. Researchers concluded that exercise has a palliative effect in patients during cancer treatment and a recuperative effect after treatment.
A review of new publications by the Update Committee for the American Society of Clinical Oncology found that the guidelines for the follow-up and management of patients with breast cancer who have completed treatment are still sound.
A number of studies conclude that breast cancer screening has little to no effect on mortality. Is it time to scrap the practice?
Women with primary breast cancer diagnosed at an advanced stage are at increased risk for the development of contralateral breast cancer (CBC), according to the results of a population-based study conducted in Sweden.